Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo. View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Christine M Fennessey, Celine Camus, Taina T Immonen, Carolyn Reid, Frank Maldarelli, Jeffrey D Lifson, Brandon F Keele

ABSTRACT

BACKGROUND: Reverse transcription (RT) of HIV and SIV is initiated by the binding of the acceptor stem of tRNALys3 to the primer binding site (PBS) of the viral RNA genome. Previous studies have suggested that this tRNALys3 is not the only molecule capable of priming reverse transcription, and that at least one other lysyl tRNA, tRNALys5, which has an acceptor stem sequence varying from tRNALys3 by only a single transition mutation resulting in the integration of a thymine (T) at position 8 of the PBS in the viral genome, can prime reverse transcription. RESULTS: We undertook an unbiased approach, evaluating the primer binding site by deep-sequencing of HIV and SIV directly from the plasma of 15 humans and 11 macaques. We found that in humans there are low but measurable levels of viral RNA genomes harboring a PBS containing the noncanonical T at position 8 (PBS-Lys5) corresponding to the tRNAlys5 sequence and representing an average of 0.52% (range 0.07-1.6%) of the total viral population. This value is remarkably consistent with the proportion of PBS-Lys5 we identified in a cross-sectional assessment of the LANL HIV database (0.51%). In macaques chronically infected with SIVmac239, the PBS-Lys5 was also detected but at a frequency 1-log less than seen for HIV, with an average of 0.056% (range 0.01-0.09%). At this proportion, PBS-Lys5 was comparable to other transition mutations, making it impossible to determine whether the mutation observed is a result of use of tRNALys5 as an RT primer at very low levels or merely the product of in vitro cDNA synthesis/PCR error. We also identified two novel PBS sequences in HIV and SIV at low levels in vivo corresponding to tRNALys6 and tRNALys1,2, suggesting that these tRNAs may rarely also be used to prime RT. In vivo reversion of the PBS-Lys5 found in SIVmac239 was rapid and reached background levels by 30 days post-infection. CONCLUSIONS: We conclude that while alternative tRNAs can initiate reverse transcription of HIV and SIV in vivo, their overall contributions to the replicating viral population are small. More... »

PAGES

11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12977-019-0473-2

DOI

http://dx.doi.org/10.1186/s12977-019-0473-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113184511

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30947720


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fennessey", 
        "givenName": "Christine M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Camus", 
        "givenName": "Celine", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Immonen", 
        "givenName": "Taina T", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reid", 
        "givenName": "Carolyn", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maldarelli", 
        "givenName": "Frank", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lifson", 
        "givenName": "Jeffrey D", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA. keelebf@mail.nih.gov."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keele", 
        "givenName": "Brandon F", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/313450a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001032663", 
          "https://doi.org/10.1038/313450a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.febslet.2009.11.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001661850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.78.19.10706-10714.2004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004922292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m301840200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006574036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.79.5.3179-3181.2005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007257998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.02643-06", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007525797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12977-015-0201-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010304530", 
          "https://doi.org/10.1186/s12977-015-0201-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.75.8.4019-4022.2001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011417099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biocel.2004.02.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012039690"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/2261209a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019844293", 
          "https://doi.org/10.1038/2261209a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1261/rna.1928110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021083891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/313277a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034786339", 
          "https://doi.org/10.1038/313277a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0300-9084(96)88114-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038002384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.00895-07", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042147239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.76.11.5803-5806.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048188062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/2261211a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048997353", 
          "https://doi.org/10.1038/2261211a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1742-4690-2-21", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049550980", 
          "https://doi.org/10.1186/1742-4690-2-21"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/088922204323048122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059200180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1099/0022-1317-78-4-837", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060360375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1570162043484988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069197429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079422606", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082392529", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082397139", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082406843", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082473914", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082831649", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083163689", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.ppat.1006359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085150375"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Reverse transcription (RT) of HIV and SIV is initiated by the binding of the acceptor stem of tRNALys3 to the primer binding site (PBS) of the viral RNA genome. Previous studies have suggested that this tRNALys3 is not the only molecule capable of priming reverse transcription, and that at least one other lysyl tRNA, tRNALys5, which has an acceptor stem sequence varying from tRNALys3 by only a single transition mutation resulting in the integration of a thymine (T) at position 8 of the PBS in the viral genome, can prime reverse transcription.\nRESULTS: We undertook an unbiased approach, evaluating the primer binding site by deep-sequencing of HIV and SIV directly from the plasma of 15 humans and 11 macaques. We found that in humans there are low but measurable levels of viral RNA genomes harboring a PBS containing the noncanonical T at position 8 (PBS-Lys5) corresponding to the tRNAlys5 sequence and representing an average of 0.52% (range 0.07-1.6%) of the total viral population. This value is remarkably consistent with the proportion of PBS-Lys5 we identified in a cross-sectional assessment of the LANL HIV database (0.51%). In macaques chronically infected with SIVmac239, the PBS-Lys5 was also detected but at a frequency 1-log less than seen for HIV, with an average of 0.056% (range 0.01-0.09%). At this proportion, PBS-Lys5 was comparable to other transition mutations, making it impossible to determine whether the mutation observed is a result of use of tRNALys5 as an RT primer at very low levels or merely the product of in vitro cDNA synthesis/PCR error. We also identified two novel PBS sequences in HIV and SIV at low levels in vivo corresponding to tRNALys6 and tRNALys1,2, suggesting that these tRNAs may rarely also be used to prime RT. In vivo reversion of the PBS-Lys5 found in SIVmac239 was rapid and reached background levels by 30\u00a0days post-infection.\nCONCLUSIONS: We conclude that while alternative tRNAs can initiate reverse transcription of HIV and SIV in vivo, their overall contributions to the replicating viral population are small.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12977-019-0473-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2343593", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1033800", 
        "issn": [
          "1742-4690"
        ], 
        "name": "Retrovirology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo.", 
    "pagination": "11", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12977-019-0473-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113184511"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101216893"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30947720"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12977-019-0473-2", 
      "https://app.dimensions.ai/details/publication/pub.1113184511"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91438_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://retrovirology.biomedcentral.com/articles/10.1186/s12977-019-0473-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12977-019-0473-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12977-019-0473-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12977-019-0473-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12977-019-0473-2'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      21 PREDICATES      56 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12977-019-0473-2 schema:about anzsrc-for:11
2 anzsrc-for:1108
3 schema:author Nd7adea5343254184a3ba36d7bed45ffc
4 schema:citation sg:pub.10.1038/2261209a0
5 sg:pub.10.1038/2261211a0
6 sg:pub.10.1038/313277a0
7 sg:pub.10.1038/313450a0
8 sg:pub.10.1186/1742-4690-2-21
9 sg:pub.10.1186/s12977-015-0201-5
10 https://app.dimensions.ai/details/publication/pub.1079422606
11 https://app.dimensions.ai/details/publication/pub.1082392529
12 https://app.dimensions.ai/details/publication/pub.1082397139
13 https://app.dimensions.ai/details/publication/pub.1082406843
14 https://app.dimensions.ai/details/publication/pub.1082473914
15 https://app.dimensions.ai/details/publication/pub.1082831649
16 https://app.dimensions.ai/details/publication/pub.1083163689
17 https://doi.org/10.1016/0300-9084(96)88114-4
18 https://doi.org/10.1016/j.biocel.2004.02.022
19 https://doi.org/10.1016/j.febslet.2009.11.038
20 https://doi.org/10.1074/jbc.m301840200
21 https://doi.org/10.1089/088922204323048122
22 https://doi.org/10.1099/0022-1317-78-4-837
23 https://doi.org/10.1128/jvi.00895-07
24 https://doi.org/10.1128/jvi.02643-06
25 https://doi.org/10.1128/jvi.75.8.4019-4022.2001
26 https://doi.org/10.1128/jvi.76.11.5803-5806.2002
27 https://doi.org/10.1128/jvi.78.19.10706-10714.2004
28 https://doi.org/10.1128/jvi.79.5.3179-3181.2005
29 https://doi.org/10.1261/rna.1928110
30 https://doi.org/10.1371/journal.ppat.1006359
31 https://doi.org/10.2174/1570162043484988
32 schema:datePublished 2019-12
33 schema:datePublishedReg 2019-12-01
34 schema:description BACKGROUND: Reverse transcription (RT) of HIV and SIV is initiated by the binding of the acceptor stem of tRNALys3 to the primer binding site (PBS) of the viral RNA genome. Previous studies have suggested that this tRNALys3 is not the only molecule capable of priming reverse transcription, and that at least one other lysyl tRNA, tRNALys5, which has an acceptor stem sequence varying from tRNALys3 by only a single transition mutation resulting in the integration of a thymine (T) at position 8 of the PBS in the viral genome, can prime reverse transcription. RESULTS: We undertook an unbiased approach, evaluating the primer binding site by deep-sequencing of HIV and SIV directly from the plasma of 15 humans and 11 macaques. We found that in humans there are low but measurable levels of viral RNA genomes harboring a PBS containing the noncanonical T at position 8 (PBS-Lys5) corresponding to the tRNAlys5 sequence and representing an average of 0.52% (range 0.07-1.6%) of the total viral population. This value is remarkably consistent with the proportion of PBS-Lys5 we identified in a cross-sectional assessment of the LANL HIV database (0.51%). In macaques chronically infected with SIVmac239, the PBS-Lys5 was also detected but at a frequency 1-log less than seen for HIV, with an average of 0.056% (range 0.01-0.09%). At this proportion, PBS-Lys5 was comparable to other transition mutations, making it impossible to determine whether the mutation observed is a result of use of tRNALys5 as an RT primer at very low levels or merely the product of in vitro cDNA synthesis/PCR error. We also identified two novel PBS sequences in HIV and SIV at low levels in vivo corresponding to tRNALys6 and tRNALys1,2, suggesting that these tRNAs may rarely also be used to prime RT. In vivo reversion of the PBS-Lys5 found in SIVmac239 was rapid and reached background levels by 30 days post-infection. CONCLUSIONS: We conclude that while alternative tRNAs can initiate reverse transcription of HIV and SIV in vivo, their overall contributions to the replicating viral population are small.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N342f50784ccc426fae3a4fe748840173
39 N9d14c3b4ed6146d29e6d7abb5e25c39d
40 sg:journal.1033800
41 schema:name Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo.
42 schema:pagination 11
43 schema:productId N070ffa5eacc044daa95ff238f5a366cc
44 N9db15afb8d1c475d9d607d4f065da524
45 Nf476bdcf2dbb428d99203ed1958dd22d
46 Nfb49a110d59648e2b0626d76ed495396
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113184511
48 https://doi.org/10.1186/s12977-019-0473-2
49 schema:sdDatePublished 2019-04-15T09:00
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N9687faf1693f4c9e9ca5fb42f9a120aa
52 schema:url https://retrovirology.biomedcentral.com/articles/10.1186/s12977-019-0473-2
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N028e1e2cd37a4c4ca536af2067ae68f1 rdf:first Ne37547a382714e728490a7d42e7d7436
57 rdf:rest rdf:nil
58 N070ffa5eacc044daa95ff238f5a366cc schema:name doi
59 schema:value 10.1186/s12977-019-0473-2
60 rdf:type schema:PropertyValue
61 N08c41b70dffd4b24828d9f0c2dcacd94 rdf:first Nf1e9ae2e42014c779b8889802bb8cfd5
62 rdf:rest Nde6f68890b0e41209eeffb9e09bdea9a
63 N29757cb4ae5849e0adbbd6610b04b3e2 rdf:first N42d6f4183e90425a9ca6ce30418f14ef
64 rdf:rest Ndf36f9487d1246f6bce343b8e469ab98
65 N2fd7ac3fe9624ea9a1e04f62f3732d30 schema:affiliation https://www.grid.ac/institutes/grid.48336.3a
66 schema:familyName Maldarelli
67 schema:givenName Frank
68 rdf:type schema:Person
69 N342f50784ccc426fae3a4fe748840173 schema:volumeNumber 16
70 rdf:type schema:PublicationVolume
71 N42d6f4183e90425a9ca6ce30418f14ef schema:affiliation https://www.grid.ac/institutes/grid.418021.e
72 schema:familyName Reid
73 schema:givenName Carolyn
74 rdf:type schema:Person
75 N4fdd3f2898484a1093f0730723ff09fc schema:affiliation https://www.grid.ac/institutes/grid.418021.e
76 schema:familyName Fennessey
77 schema:givenName Christine M
78 rdf:type schema:Person
79 N9687faf1693f4c9e9ca5fb42f9a120aa schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N9d14c3b4ed6146d29e6d7abb5e25c39d schema:issueNumber 1
82 rdf:type schema:PublicationIssue
83 N9db15afb8d1c475d9d607d4f065da524 schema:name nlm_unique_id
84 schema:value 101216893
85 rdf:type schema:PropertyValue
86 Nbd76f7592013480b9e6a49763789f553 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
87 schema:familyName Immonen
88 schema:givenName Taina T
89 rdf:type schema:Person
90 Nbfc700ba06314b7e9d5099906eca4d93 rdf:first Nee121ae2aa7f424b80af0141ce494b39
91 rdf:rest N028e1e2cd37a4c4ca536af2067ae68f1
92 Nd7adea5343254184a3ba36d7bed45ffc rdf:first N4fdd3f2898484a1093f0730723ff09fc
93 rdf:rest N08c41b70dffd4b24828d9f0c2dcacd94
94 Nde6f68890b0e41209eeffb9e09bdea9a rdf:first Nbd76f7592013480b9e6a49763789f553
95 rdf:rest N29757cb4ae5849e0adbbd6610b04b3e2
96 Ndf36f9487d1246f6bce343b8e469ab98 rdf:first N2fd7ac3fe9624ea9a1e04f62f3732d30
97 rdf:rest Nbfc700ba06314b7e9d5099906eca4d93
98 Ne37547a382714e728490a7d42e7d7436 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
99 schema:familyName Keele
100 schema:givenName Brandon F
101 rdf:type schema:Person
102 Nee121ae2aa7f424b80af0141ce494b39 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
103 schema:familyName Lifson
104 schema:givenName Jeffrey D
105 rdf:type schema:Person
106 Nf1e9ae2e42014c779b8889802bb8cfd5 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
107 schema:familyName Camus
108 schema:givenName Celine
109 rdf:type schema:Person
110 Nf476bdcf2dbb428d99203ed1958dd22d schema:name dimensions_id
111 schema:value pub.1113184511
112 rdf:type schema:PropertyValue
113 Nfb49a110d59648e2b0626d76ed495396 schema:name pubmed_id
114 schema:value 30947720
115 rdf:type schema:PropertyValue
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical Microbiology
121 rdf:type schema:DefinedTerm
122 sg:grant.2343593 http://pending.schema.org/fundedItem sg:pub.10.1186/s12977-019-0473-2
123 rdf:type schema:MonetaryGrant
124 sg:journal.1033800 schema:issn 1742-4690
125 schema:name Retrovirology
126 rdf:type schema:Periodical
127 sg:pub.10.1038/2261209a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019844293
128 https://doi.org/10.1038/2261209a0
129 rdf:type schema:CreativeWork
130 sg:pub.10.1038/2261211a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048997353
131 https://doi.org/10.1038/2261211a0
132 rdf:type schema:CreativeWork
133 sg:pub.10.1038/313277a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034786339
134 https://doi.org/10.1038/313277a0
135 rdf:type schema:CreativeWork
136 sg:pub.10.1038/313450a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001032663
137 https://doi.org/10.1038/313450a0
138 rdf:type schema:CreativeWork
139 sg:pub.10.1186/1742-4690-2-21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049550980
140 https://doi.org/10.1186/1742-4690-2-21
141 rdf:type schema:CreativeWork
142 sg:pub.10.1186/s12977-015-0201-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010304530
143 https://doi.org/10.1186/s12977-015-0201-5
144 rdf:type schema:CreativeWork
145 https://app.dimensions.ai/details/publication/pub.1079422606 schema:CreativeWork
146 https://app.dimensions.ai/details/publication/pub.1082392529 schema:CreativeWork
147 https://app.dimensions.ai/details/publication/pub.1082397139 schema:CreativeWork
148 https://app.dimensions.ai/details/publication/pub.1082406843 schema:CreativeWork
149 https://app.dimensions.ai/details/publication/pub.1082473914 schema:CreativeWork
150 https://app.dimensions.ai/details/publication/pub.1082831649 schema:CreativeWork
151 https://app.dimensions.ai/details/publication/pub.1083163689 schema:CreativeWork
152 https://doi.org/10.1016/0300-9084(96)88114-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038002384
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.biocel.2004.02.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012039690
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.febslet.2009.11.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001661850
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1074/jbc.m301840200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006574036
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1089/088922204323048122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059200180
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1099/0022-1317-78-4-837 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060360375
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1128/jvi.00895-07 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042147239
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1128/jvi.02643-06 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007525797
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1128/jvi.75.8.4019-4022.2001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011417099
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1128/jvi.76.11.5803-5806.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048188062
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1128/jvi.78.19.10706-10714.2004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004922292
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1128/jvi.79.5.3179-3181.2005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007257998
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1261/rna.1928110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021083891
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1371/journal.ppat.1006359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085150375
179 rdf:type schema:CreativeWork
180 https://doi.org/10.2174/1570162043484988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069197429
181 rdf:type schema:CreativeWork
182 https://www.grid.ac/institutes/grid.418021.e schema:alternateName Frederick National Laboratory for Cancer Research
183 schema:name AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
184 AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA. keelebf@mail.nih.gov.
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.48336.3a schema:alternateName National Cancer Institute
187 schema:name HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, 21702, USA.
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...